Abstract
Diabetic macular edema (DME) is the leading cause of moderate vision loss in diabetics. Modalities to image and monitor DME have evolved much in the last decade. Systemic control is the most important part of management. Available ocular management options include intravitreal antivascular endothelial growth factor (anti-VEGF) agents, laser, steroids (intravitreal or peribulbar), vitrectomy, topical medications and others. Anti-VEGF agents are increasingly being used in clinical practice with good clinical response and are currently the preferred mode of treatment worldwide.
Keywords: Aflibercept, aspirin, bevacizumab, diabetic retinopathy, glitazones, iluvien, i-vation, mecamylamine, medidur, midostaurin, nepafenac, ozurdex, PASCAL, ranibizumab, retisert, ruboxistaurin, selective retina therapy (SRT), sorbinil, subthreshold micropulse diode laser photocoagulation, VEGF.
Current Diabetes Reviews
Title:Recent Advances in Management of Diabetic Macular Edema
Volume: 11 Issue: 2
Author(s): Koushik Tripathy, Yog Raj Sharma, Karthikeya R, Rohan Chawla, Varun Gogia, Subodh Kumar Singh, Pradeep Venkatesh and Rajpal Vohra
Affiliation:
Keywords: Aflibercept, aspirin, bevacizumab, diabetic retinopathy, glitazones, iluvien, i-vation, mecamylamine, medidur, midostaurin, nepafenac, ozurdex, PASCAL, ranibizumab, retisert, ruboxistaurin, selective retina therapy (SRT), sorbinil, subthreshold micropulse diode laser photocoagulation, VEGF.
Abstract: Diabetic macular edema (DME) is the leading cause of moderate vision loss in diabetics. Modalities to image and monitor DME have evolved much in the last decade. Systemic control is the most important part of management. Available ocular management options include intravitreal antivascular endothelial growth factor (anti-VEGF) agents, laser, steroids (intravitreal or peribulbar), vitrectomy, topical medications and others. Anti-VEGF agents are increasingly being used in clinical practice with good clinical response and are currently the preferred mode of treatment worldwide.
Export Options
About this article
Cite this article as:
Tripathy Koushik, Sharma Yog Raj, R Karthikeya, Chawla Rohan, Gogia Varun, Kumar Singh Subodh, Venkatesh Pradeep and Vohra Rajpal, Recent Advances in Management of Diabetic Macular Edema, Current Diabetes Reviews 2015; 11 (2) . https://dx.doi.org/10.2174/1573399811999150324120640
DOI https://dx.doi.org/10.2174/1573399811999150324120640 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Migraine Attack Treatment : A Tailor-made Suit, Not One Size Fits All
Recent Patents on CNS Drug Discovery (Discontinued) Highly Active Antiretroviral Therapy and Cardiovascular Complications in HIV-Infected Patients
Current Pharmaceutical Design Resveratrol and Cancer Treatment: Is Hormesis a Yet Unsolved Matter?
Current Pharmaceutical Design Modification of Lifestyle Factors are Needed to Improve the Metabolic Health of Patients with Cardiovascular Disease Risk
Current Pharmaceutical Design Possible Involvement of TRP Channels in Cardiac Hypertrophy and Arrhythmia
Current Topics in Medicinal Chemistry New Strategies in Treatment of Mineral and Bone Disorders and Associated Cardiovascular Disease in Patients with Chronic Kidney Disease
Recent Patents on Cardiovascular Drug Discovery Recent Patents on PCSK9: A New Target for Treating Hypercholesterolemia
Recent Patents on DNA & Gene Sequences The Role of Vitamin D in Gastrointestinal Diseases: Inflammation, Gastric Cancer, and Colorectal Cancer
Current Medicinal Chemistry High-Throughput Functional Genomic Methods to Analyze the Effects of Dietary Lipids
Current Pharmaceutical Biotechnology The Role of Oxidative Stress in Depressive Disorders
Current Pharmaceutical Design Renal Innervation in Resistant Hypertension: A Review of Pathophysiology and Renal Denervation as Potential Treatment
Current Hypertension Reviews 10 Years of SELDI: What Have we Learnt?
Current Proteomics Vitamin D Intake and Obesity in Occupational Asthma Patients and the Need for Supplementation
Endocrine, Metabolic & Immune Disorders - Drug Targets Editorial [Hot topic:Vascular Protective Effects of Ezetimibe: Seeking New Therapeutic Possibilities of Ezetimibe in Vascular Disease (Guest Editor: Minako Yamaoka-Tojo)]
Current Vascular Pharmacology Fungal Bioactive Compounds in Pharmaceutical Research and Development
Current Bioactive Compounds Protective Effects of Pomegranate in Endothelial Dysfunction
Current Pharmaceutical Design Microvascular Thrombosis: An Exciting but Elusive Therapeutic Target in Reperfused Acute Myocardial Infarction
Cardiovascular & Hematological Disorders-Drug Targets The Role of Endogenous H2S in Cardiovascular Physiology
Current Pharmaceutical Biotechnology Angiotensin II and Abdominal Aortic Aneurysms: An update
Current Pharmaceutical Design Novel Therapies for Schizophrenia: Understanding the Glutamatergic Synapse and Potential Targets for Altering N-methyl-D-aspartate Neurotransmission
Recent Patents on CNS Drug Discovery (Discontinued)